These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12824030)

  • 21. Effects of NCX 4050, a new NO donor, in rabbit and human corpus cavernosum.
    Filippi S; Crescioli C; Vannelli GB; Fazzini A; Natali A; Riffaud JP; Maggi M; Ledda F
    Int J Androl; 2003 Apr; 26(2):101-8. PubMed ID: 12641828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1-Arylnaphthalene lignan: a novel scaffold for type 5 phosphodiesterase inhibitor.
    Ukita T; Nakamura Y; Kubo A; Yamamoto Y; Takahashi M; Kotera J; Ikeo T
    J Med Chem; 1999 Apr; 42(7):1293-305. PubMed ID: 10197972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphodiesterase type 5 as a pharmacologic target in erectile dysfunction.
    Corbin JD; Francis SH; Webb DJ
    Urology; 2002 Sep; 60(2 Suppl 2):4-11. PubMed ID: 12414329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro effects of PDE5 inhibitors sildenafil, vardenafil and tadalafil on isolated human ureteral smooth muscle: a basic research approach.
    Gratzke C; Uckert S; Kedia G; Reich O; Schlenker B; Seitz M; Becker AJ; Stief CG
    Urol Res; 2007 Feb; 35(1):49-54. PubMed ID: 17102958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative effects of sildenafil, phentolamine, yohimbine and L-arginine on the rabbit corpus cavernosum.
    Sharabi FM; Daabees TT; El-Metwally MA; Senbel AM
    Fundam Clin Pharmacol; 2004 Apr; 18(2):187-94. PubMed ID: 15066133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T-0156, a novel phosphodiesterase type 5 inhibitor, and sildenafil have different pharmacological effects on penile tumescence and electroretinogram in dogs.
    Mochida H; Noto T; Inoue H; Yano K; Kikkawa K
    Eur J Pharmacol; 2004 Feb; 485(1-3):283-8. PubMed ID: 14757152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changed phosphodiesterase selectivity and enhanced in vitro efficacy by selective deuteration of sildenafil.
    Schneider F; Mattern-Dogru E; Hillgenberg M; Alken RG
    Arzneimittelforschung; 2007; 57(6):293-8. PubMed ID: 17688073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and SAR of tetracyclic pyrroloquinolones as phosphodiesterase 5 inhibitors.
    Jiang W; Alford VC; Qiu Y; Bhattacharjee S; John TM; Haynes-Johnson D; Kraft PJ; Lundeen SG; Sui Z
    Bioorg Med Chem; 2004 Mar; 12(6):1505-15. PubMed ID: 15018924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allosteric sites of phosphodiesterase-5 (PDE5). A potential role in negative feedback regulation of cGMP signaling in corpus cavernosum.
    Gopal VK; Francis SH; Corbin JD
    Eur J Biochem; 2001 Jun; 268(11):3304-12. PubMed ID: 11389733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and phosphodiesterase 5 inhibitory activity of novel phenyl ring modified sildenafil analogues.
    Kim DK; Lee N; Lee JY; Ryu DH; Kim JS; Lee SH; Choi JY; Chang K; Kim YW; Im GJ; Choi WS; Kim TK; Ryu JH; Kim NH; Lee K
    Bioorg Med Chem; 2001 Jun; 9(6):1609-16. PubMed ID: 11408180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of sildenafil analogues from anacardic acid and their phosphodiesterase-5 inhibition.
    Paramashivappa R; Phani Kumar P; Subba Rao PV; Srinivasa Rao A
    J Agric Food Chem; 2002 Dec; 50(26):7709-13. PubMed ID: 12475293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [3H]sildenafil binding to phosphodiesterase-5 is specific, kinetically heterogeneous, and stimulated by cGMP.
    Corbin JD; Blount MA; Weeks JL; Beasley A; Kuhn KP; Ho YS; Saidi LF; Hurley JH; Kotera J; Francis SH
    Mol Pharmacol; 2003 Jun; 63(6):1364-72. PubMed ID: 12761347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sildenafil inhibits phosphodiesterase type 5 in human clitoral corpus cavernosum smooth muscle.
    Park K; Moreland RB; Goldstein I; Atala A; Traish A
    Biochem Biophys Res Commun; 1998 Aug; 249(3):612-7. PubMed ID: 9731184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphodiesterase type 5 inhibitors: molecular pharmacology and interactions with other phosphodiesterases.
    Seftel AD
    Curr Pharm Des; 2005; 11(31):4047-58. PubMed ID: 16378510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel compound JPM8: in vivo penile activity promotion in rats, effect on the relaxation and cGMP/cAMP accumulation in isolated rabbit corpora cavernosa.
    El-Thaher TS; Khatib S; Saleem M; Shnoudeh A; Badwan AA
    Int J Impot Res; 2002 Dec; 14(6):453-61. PubMed ID: 12494277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substituted pyrazolopyridines as potent and selective PDE5 inhibitors: potential agents for treatment of erectile dysfunction.
    Yu G; Mason HJ; Wu X; Wang J; Chong S; Dorough G; Henwood A; Pongrac R; Seliger L; He B; Normandin D; Adam L; Krupinski J; Macor JE
    J Med Chem; 2001 Mar; 44(7):1025-7. PubMed ID: 11297448
    [No Abstract]   [Full Text] [Related]  

  • 37. Sildenafil and T-1032, phosphodiesterase type 5 inhibitors, showed a different vasorelaxant property in the isolated rat aorta.
    Mochida H; Inoue H; Takagi M; Noto T; Yano K; Kikkawa K
    Eur J Pharmacol; 2002 Apr; 440(1):45-52. PubMed ID: 11959087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells.
    Wharton J; Strange JW; Møller GM; Growcott EJ; Ren X; Franklyn AP; Phillips SC; Wilkins MR
    Am J Respir Crit Care Med; 2005 Jul; 172(1):105-13. PubMed ID: 15817798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The discovery of tadalafil: a novel and highly selective PDE5 inhibitor. 2: 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione analogues.
    Daugan A; Grondin P; Ruault C; Le Monnier de Gouville AC; Coste H; Linget JM; Kirilovsky J; Hyafil F; Labaudinière R
    J Med Chem; 2003 Oct; 46(21):4533-42. PubMed ID: 14521415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relaxation effect of nitric oxide-donor on diabetic penile smooth muscle in vitro.
    Taher A; Birowo P; Kamil ST; Shahab N
    Clin Hemorheol Microcirc; 2000; 23(2-4):277-81. PubMed ID: 11321451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.